Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:9999
SEHK:9999Entertainment

3 Video Game Stocks Investors May Revisit After Microsoft’s Xbox Reset

Restructuring at Microsoft’s Xbox arm has put gaming back under the microscope, as studios are merged, shuttered or handed to Activision, and that ripple can reshape where future cash flows in this sector actually sit. Investors watching this shift risk missing it until after the market moves. This article reviews the news and highlights 3 video game stocks exposed to these changes for investors who want to take a closer look right now. The stocks below are just a starting sample from this...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

What NetScout Systems (NTCT)'s AI Data Access Upgrade Means For Shareholders

NetScout Systems recently announced Model Context Protocol connectivity for its Omnis AI Insights platform, giving AI assistants on-demand access to its AI-ready Smart Data built from Adaptive Service Intelligence and integrated through Omnis Sensor and Omnis Streamer. The update pushes network intelligence closer to the data source and aims to cut telemetry processing costs while making existing NetScout deployments more useful across AIOps, observability, security, and analytics...
NasdaqGS:ADSK
NasdaqGS:ADSKSoftware

3 Undervalued Stocks Trading At Least 36% Below Fair Value

AI optimism has just pushed the Nasdaq 100 close to a record high, and that surge reminds investors where most attention currently sits. Cash rich but underappreciated businesses can get left in the shadows when headlines fixate on growth stories. That gap between cash power and market price is where opportunity lives. This article highlights three stocks that screen as potentially mispriced on future cash flows. The three stocks below are just a small sample, since the full cash flow screen...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

What Monte Rosa Therapeutics (GLUE)'s Phase 2 Trial Start Means For Shareholders

Monte Rosa Therapeutics reported that Novartis initiated a Phase 2a/b trial of VAV1-directed degrader MRT-6160 in Sjögren's disease, triggering a US$50 million milestone payment under their global exclusive license agreement. The MRT-6160 collaboration structure gives Novartis global development control, while Monte Rosa retains U.S. profit sharing and ex-U.S. royalty potential, which concentrates near-term cash inflows and longer-term economic upside around this single asset class. The...
OM:NCC B
OM:NCC BConstruction

Will Long Term Partnering Deal Change NCC Stock Narrative

NCC has recently announced a ten year partnering agreement for multiple construction and civil engineering projects worth an estimated SEK 3–5b, alongside several large public and private contracts in Sweden, Finland and Denmark that span offices, care facilities and government premises. Together, these agreements point to a thicker project pipeline for NCC, with long duration work structured in partnering and alliance models. This can influence capacity planning, risk sharing and the mix of...
ENXTPA:ERF
ENXTPA:ERFLife Sciences

3 European Life Science Tools Stocks Investors May Want To Watch Now

Europe’s big drug makers are warning that the region is slipping in the global race for R&D and clinical trials, and that shift could quietly reshape where capital flows next. If governments respond with friendlier rules and funding, the real beneficiaries may be the lab tool suppliers and clinical service providers working behind the scenes. This article walks through 3 stocks from our European life-science tools screener that appear closely tied to this turning point. The three stocks...
NZSE:MEL
NZSE:MELRenewable Energy

Is Strong August Generation Altering The Investment Case For Meridian Energy (NZSE:MEL)?

Meridian Energy reported operating results for August 2026, with total generation of 1,432 GWh compared with 1,179 GWh in August 2025. The large year on year gap in monthly output highlights how Meridian Energy’s asset utilisation and hydrology conditions can quickly reshape its operating profile. This article considers how Meridian Energy’s investment narrative is affected by this strong August generation volume and what it may signal. Scan other renewable operators that show similar...
NasdaqCM:SHAZ
NasdaqCM:SHAZIT

Nvidia And Seagate Stock Lead This US AI Infrastructure Screen

AI infrastructure has moved from buzzword to battlefront as Washington wrestles with war in Iran, sticky inflation, a swelling US$40b plus public debt load, and a White House that is relaxed about regulating the technology. That mix of risk and freedom is reshaping how capital chases data centers, chips, and power. This article spotlights three US stocks exposed to that news backdrop and explains why they merit a closer look today. The stocks highlighted below are just a starting sample, and...
NYSE:VZ
NYSE:VZTelecom

Verizon Communications (VZ) Expands Its Network Push As Valuation Stays In Focus

Verizon Communications (VZ) has been active on the product front in September, from a new push to mission-critical devices with Siyata’s SD7 Ultra 5G handset to an expanded 6G Innovation Forum and fresh Apple hardware launches. Despite this steady stream of product launches and network initiatives, Verizon Communications’ recent trading has been choppy, with the share price down 7.0% over the past week and 3.6% over the past month, yet still showing a 17.7% year-to-date share price return and...
NasdaqGS:LEGN
NasdaqGS:LEGNBiotechs

Did CEO Appointment Just Shift Legend Biotech Stock Investment Narrative?

Legend Biotech appointed Ingrid Zhang as CEO on 15 September 2026, bringing extensive commercial leadership experience from Novartis, AstraZeneca, Pfizer, and McKinsey to oversee a broad and clinically active cell therapy pipeline. Her background running major markets and complex product launches aligns closely with Legend Biotech’s expanding CARVYKTI program and multi-modality pipeline that spans autologous, allogeneic, and in vivo cell therapies across oncology and autoimmune...
XTRA:EVK
XTRA:EVKChemicals

Is Evonik Industries (XTRA:EVK) Fully Valued Or Is There Still Upside?

Evonik Industries (XTRA:EVK) has drawn fresh attention after its recent share move, with the price closing at €17.98. Investors are weighing this level against the latest fundamentals and valuation signals. Recent trading has pushed Evonik Industries to a €17.98 share price after a 1 day share price return of 4.29%, capping a year to date share price return of 35.09% and a 1 year total shareholder return of 23.54%. This suggests that momentum has been building rather than fading. Scan how...
TSE:6501
TSE:6501Industrials

Top 3 Japanese Nuclear Stocks To Watch In September 2026

Oil markets are back in focus after Saudi Arabia signaled plans to restart its key East West pipeline, reminding investors how fragile global energy supply can be. When fuel routes look uncertain, reliable baseload power such as Japanese nuclear energy can draw fresh attention. This article walks through three stocks from Japan’s nuclear power universe to help you understand where some investors are focusing in this shifting energy story. The stocks below are just a starting sample from...
NYSE:MSGE
NYSE:MSGEEntertainment

Madison Square Garden Entertainment (MSGE) Names A New President, Is It Still 11% Below Fair Value?

Leadership change puts Madison Square Garden Entertainment in focus Madison Square Garden Entertainment (MSGE) has moved longtime executive Josephine Vaccarello into the President role, giving her direct oversight of concert bookings, non-Knicks and non-Rangers sports events, and the Rockettes productions portfolio. Recent trading has reflected that shift in attention. Madison Square Garden Entertainment’s share price has climbed 49.43% year to date, and the 1-year total shareholder return of...
TSX:MFI
TSX:MFIFood

Will Yves Return Change Maple Leaf Foods Stock Narrative

Maple Leaf Foods has brought Yves Veggie Cuisine back to Canadian grocery shelves, reintroducing six refrigerated plant-based staples across multiple retail partners. The move puts a familiar, ready-to-use plant protein brand back into everyday meal routines. It reinforces Maple Leaf Foods' presence in the plant-based aisle without requiring consumers to change how they cook. We will look at how Maple Leaf Foods' investment narrative is affected by reviving Yves Veggie Cuisine as a core...
NYSE:COTY
NYSE:COTYPersonal Products

Learn Why The Bull Case For Coty (COTY) Could Change Following Weak Revenue Outlook

Coty’s core operations have underperformed expectations, with weak organic revenue and a forecast revenue decline, while recent share issuances have diluted earnings per share. The combination of a softer core business and falling earnings per share raises questions about whether Coty must rely on acquisitions for growth. We will now assess how Coty’s weaker organic revenue and outlook could reshape the existing investment narrative around the business. Spot potential alternatives to Coty...
ENXTPA:ANTIN
ENXTPA:ANTINCapital Markets

Do Lower Half Year Earnings Change The Bull Case For Antin Infrastructure Partners Stock?

Antin Infrastructure Partners reported half year 2026 results with revenue of €138.48 million, net income of €46.62 million and basic EPS of €0.26, all lower than the same period a year earlier. The Board approved an interim dividend of €0.28 per share, or €50.2 million in total. This puts fresh attention on how much cash is being returned to investors versus retained to fund future infrastructure opportunities. Now the focus turns to how Antin Infrastructure Partners' softer half year...
NasdaqGS:CHKP
NasdaqGS:CHKPSoftware

Learn Why The Bull Case For Check Point Stock Could Change Following Index Removal

Check Point Software Technologies was removed from the FTSE All-World Index following prior share price weakness, even as it holds a Leader position in Gartner's Hybrid Mesh Firewall report, reflecting its role in hybrid network security. The index exit may influence institutional ownership and passive fund flows at the same time investors are reassessing how its firewall heritage and AI driven security products relate to future cash generation. This article examines how Check Point Software...
NZSE:IFT
NZSE:IFTDiversified Financial

Did Analyst Day Updates Just Shift Infratil (NZSE:IFT) Stock's Investment Narrative?

Infratil recently held an Analyst and Investor Day, where management walked through current operations, capital allocation priorities, and portfolio positioning across its infrastructure holdings. The event gave investors a closer look at how Infratil is considering growth projects, cost discipline, and regulatory exposure across its key platforms. Now the focus shifts to how Infratil's investment narrative evolves in light of the additional detail shared at its Analyst and Investor...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Domino's Pizza (DPZ) Joins Skip In Canada, Is The Stock Still Cheap?

Domino's Pizza (DPZ) is back in focus after joining the Skip delivery network in Canada, a move aimed at widening reach and adding fresh promotional power in a crowded delivery market. Recent trading has been choppy for Domino's Pizza. The share price is now US$295.94 after falling about 13% over the past month and more than 30% year to date, while the 1 year total shareholder return is also down sharply. This hints that investors have been reassessing both growth prospects and risk, even as...
SEHK:2442
SEHK:2442Construction

Is Easy Smart Group Holdings (SEHK:2442) Fully Valued After Its Loss Guidance Shock?

Easy Smart Group Holdings (SEHK:2442) issued fresh guidance for the year to 30 June 2026, indicating an expected loss of up to HK$32 million, compared with about HK$0.5 million previously. That guidance dropped into a wild year for Easy Smart Group Holdings, where the share price has surged 246.37% year to date and delivered a very large 1-year total shareholder return of 1,891.12%, even as the 7-day share price return fell 56.10% and short term momentum cooled against that longer term...
NasdaqGS:KMTS
NasdaqGS:KMTSMedical Equipment

Why Kestra Medical Technologies (KMTS) Is Back In Focus

Why Kestra Medical Technologies Is Back In Focus Kestra Medical Technologies (KMTS) moved into the spotlight after first quarter results showed sales of US$30.97 million, a net loss of US$44.09 million, and an updated fiscal 2027 revenue outlook of US$141 million. The first quarter update and higher 2027 revenue outlook have arrived after a mixed stretch for Kestra Medical Technologies, with a 19.72% 90 day share price return, an 8.23% decline over 30 days, and a 1 year total shareholder...
NYSE:AGCO
NYSE:AGCOMachinery

AGCO (AGCO) Faces The Valuation Question As Growth Narrative Stays In Focus

AGCO (AGCO) is set to present at Morgan Stanley's 14th Annual Laguna Conference on 15 September 2026. The event will put the agricultural equipment maker in front of institutional investors watching its recent share performance. Recent trading shows AGCO building moderate momentum, with a 30-day share price return of 12.26% and a 90-day gain of 7.80%. The 1-year total shareholder return of 10.68% and 5-year total shareholder return of 9.33% point to steadier longer term progress. Look beyond...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Why Everyone Is Watching Travere Therapeutics (TVTX) Today

Leadership change at Travere Therapeutics Travere Therapeutics (TVTX) has set out a detailed leadership handover after announcing that Eric Dube will step down as CEO, president, and board member on December 1, 2026. Investors have already been reassessing Travere Therapeutics around this planned transition. The share price is $62.86 after a year-to-date share price return of 59.06% and a one-year total shareholder return of 147.19%. The recent 30-day share price return of 4.34% and 7-day...
NYSE:CRCL
NYSE:CRCLSoftware

Circle Internet Group (CRCL) Shares Climbed, What Is Behind The Move?

Circle Internet Group (CRCL) just raised roughly US$100m through a private placement to Binance, issuing 1,237,011 Class A shares at US$80.84 each. This funding event gives investors fresh data on valuation and capital needs. The fresh equity comes on the heels of Arc’s public mainnet launch and SEC support for tokenized trading. The share price has climbed to US$94.49 with a 30 day share price return of 7.4% and a 90 day gain of 24.9%, even as the 1 year total shareholder return is still...